Biotech venture capital off to a $659m start in 2015

Just six days into 2015, the US biotechnology industry already is halfway to the $1.1bn in venture capital raised during the first three months of 2014, including a $48m Series B round for Global Blood Therapeutics (GBT), a $65m Series D for Seres Health and a $20m Series C for CytomX.

Just six days into 2015, the US biotechnology industry already is halfway to the $1.1bn in venture capital raised during the first three months of 2014, including a $48m Series B round for Global Blood Therapeutics (GBT), a $65m Series D for Seres Health and a $20m Series C for CytomX.

The three 6 January VC funding announcements were preceded by $76.4m in new financings for Aduro Biotech, Symic Biomedical and...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category